In summary, the identification of bi-allelic disease-associated repeat expansions in RFC1 fundamentally changes the genetic spectrum of HSAN and raises the overall diagnostic rate up to 44.3%. This evidence concerns the gene RFC1 and hereditary sensory and autonomic neuropathy.